Logic-gated monoclonal antibodies have been designed to improve safety and efficacy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Christian, B. A. & Lin, T. S. Semin. Hematol. 45, 95–103 (2008).
Alinari, L. et al. Oncogene 26, 3644–3653 (2007).
Oostindie, S. C. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01384-1 (2022).
Lajoie, M. J. et al. Science 369, 1637–1643 (2020).
Roybal, K. T. et al. Cell 164, 770–779 (2016).
Banaszek, A. et al. Nat. Commun. 10, 5387 (2019).
Diebolder, C. A. et al. Science 343, 1260–1263 (2014).
Oostindie, S. C. et al. Haematologica 104, 1841–1852 (2019).
Macor, P., Capolla, S. & Tedesco, F. Front. Immunol. 9, 2203 (2018).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors are employed by Seagen, Inc.
Rights and permissions
About this article
Cite this article
Lawrence, R.T., Senter, P.D. Precision cancer targeting with antibody pairs. Nat Biotechnol 40, 1434–1435 (2022). https://doi.org/10.1038/s41587-022-01401-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01401-3